One Health Group Plc

Declaration of Voting Results & Voting Rights Announcements • Feb 26, 2024

National Storage Mechanism | Additional information

RNS Number : 3410E

One Health Group PLC

26 February 2024

26 February 2024

One Health Group plc

("One Health" or the "Company")

Exercise of options and Total Voting Rights

One Health (AQSE: OHGR), a provider of NHS-funded medical procedures, announces that it has issued 40,000 new ordinary shares of 0.5 pence each in the Company (the "New Ordinary Shares") pursuant to the exercise of options under the One Health Group Share Option Plan.

Last year, 19 consultants exercised their share options. A further two consultants have now exercised their share options (as above) and there remain seven consultants with unexercised options.

An application has been made for the New Ordinary Shares to be admitted to trading on the Apex segment of the AQSE Growth Market ("Admission"). It is expected that Admission will become effective at 8.00 a.m. on or around 29 February 2024.

Following Admission, the total number of ordinary shares and voting rights in the Company will be 10,550,093. The Company does not hold any shares in treasury.

The above figure of 10,550,093 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules. 

The directors of One Health accept responsibility for this announcement.

Ends

Enquiries:

One Health Group plc	Via Square1 Consulting
Oberon Capital (AQSE Corporate Adviser and Broker) Nick Lovering, Mike Seabrook	020 3179 5300
Square 1 Consulting David Bick	020 7929 5599

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXEAXADADLLEFA